Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Altimmune (ALT) over the last 12 years, with Q3 2025 value amounting to 0.48%.

  • Altimmune's Return on Invested Capital changed N/A to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year change of. This contributed to the annual value of 0.45% for FY2022, which is N/A changed from last year.
  • Altimmune's Return on Invested Capital amounted to 0.48% in Q3 2025.
  • Over the past 5 years, Altimmune's Return on Invested Capital peaked at 0.25% during Q1 2021, and registered a low of 0.73% during Q1 2025.
  • For the 3-year period, Altimmune's Return on Invested Capital averaged around 0.45%, with its median value being 0.45% (2022).
  • Per our database at Business Quant, Altimmune's Return on Invested Capital soared by 3200bps in 2021 and then crashed by -700bps in 2022.
  • Altimmune's Return on Invested Capital (Quarter) stood at 0.37% in 2021, then dropped by -21bps to 0.45% in 2022, then decreased by -6bps to 0.48% in 2025.
  • Its last three reported values are 0.48% in Q3 2025, 0.59% for Q2 2025, and 0.73% during Q1 2025.